Patents by Inventor Abigail Kennedy

Abigail Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Raf Modulators and Methods of Use
    Publication number: 20080009488
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Raf. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: March 25, 2005
    Publication date: January 10, 2008
    Applicant: EXELIXIS, INC.
    Inventors: Neel Anand, Charles Blazey, Owen Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Curtis, Larisa Dubenko, Abigail Kennedy, Steven Defina, Angie Kim, Jean-Claire Manalo, Csaba Peto, Kenneth Rice, Tsze Tsang, Anagha Joshi
  • Anaplastic lymphoma kinase modulators and methods of use
    Publication number: 20070032515
    Abstract: The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
    Type: Application
    Filed: July 23, 2004
    Publication date: February 8, 2007
    Applicant: Exelixis, Inc.
    Inventors: Neel Anand, Charles Blazey, Owen Bowles, Joerg Bussenius, Simona Costanzo, Jeffry Curtis, Larisa Dubenko, Abigail Kennedy, Richard Khoury, Angie Kim, Jean-Claire Manalo, Csaba Peto, Kenneth Rice, Tsze Tsang
  • Protein kinase modulators and methods of use
    Publication number: 20060211709
    Abstract: Substituted aryl 1,4-pyrazine derivatives and their use in treating anxiety disorders, depression and stress related disorders are disclosed.
    Type: Application
    Filed: May 2, 2003
    Publication date: September 21, 2006
    Inventors: Chris Buhr, Tae-Gon Baik, Sunghoon Ma, Zerom Tesfai, Longcheng Wang, Erick Co, Sergey Epshteyn, Abigail Kennedy, Baili Chen, Larisa Dubenko, Neel Anand, Tsze Tsang, John Nuss, Csabaj Peto, Kenneth Rice, Mohamed Ibrahim, Xian Shi, James Leahy, Jeff Chen, Lisa Dalrymple, Timothy Forsyth, Tai Huynh, Grace Mann, Larry Mann, Craig Takeuchi
  • Receptor-type kinase modulators and methods of use
    Publication number: 20060069077
    Abstract: The present invention provides compounds for modulating receptor kinase activity, particularly ephrin and EGFR, and methods of treating diseases mediated by receptor kinase activity utilizing the compounds and pharmaceutical compositions thereof. Diseases mediated by receptor kinase activity include, but are not limited to, diseases characterized in part by abnormal levels of cell proliferation (i.e. tumor growth), programmed cell death (apoptosis), cell migration and invasion and angiogenesis associated with tumor growth. Compounds of the invention include “spectrum selective” kinase modulators, compounds that inhibit, regulate and/or modulate signal transduction across subfamilies of receptor-type tyrosine kinases, including ephrin and EGFR.
    Type: Application
    Filed: July 14, 2003
    Publication date: March 30, 2006
    Inventors: Kenneth Rice, Neel Anand, Joerg Bussenius, Simona Costanzo, Abigail Kennedy, Angie Kim, Csaba Peto, Tsze Tsang, Charles Blazey